| Entry |
|
|---|
| Name |
Amfetamine (INN);
Amphetamine;
Amfetamin (TN)
|
|---|
| Formula |
C9H13N
|
|---|
| Exact mass |
135.1048
|
|---|
| Mol weight |
135.2062
|
|---|
| Structure |
     |
|---|
| Activity |
Psychostimulant
|
|---|
| Remark |
|
|---|
| Target |
noradrenalin transporter inhibitor [HSA: 6530] [KO: K05035]; dopamine transporter inhibitor [HSA: 6531] [KO: K05036]; serotonin transporter inhibitor [HSA: 6532] [KO: K05037] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Pathway map |
|
|---|
| Structure map |
| Neurotransmitter transporter inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06BA Centrally acting sympathomimetics
N06BA01 Amfetamine
D07445 Amfetamine (INN)
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (noradrenalin transporter) [HSA:6530] [KO:K05035]
Amfetamine [ATC:N06BA01]
D07445 Amfetamine (INN)
SLC6A3 (dopamine transporter) [HSA:6531] [KO:K05036]
Amfetamine [ATC:N06BA01]
D07445 Amfetamine (INN)
 |
|---|
| Other DBs |
CAS: 300-62-9 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 10
1 C8y C 26.3200 -17.7100
2 C8x C 25.1300 -17.0100
3 C8x C 26.3200 -19.1100
4 C1b C 27.5100 -17.0100
5 C8x C 23.8700 -17.7100
6 C8x C 25.1300 -19.8100
7 C1c C 28.7700 -17.7100
8 C8x C 23.8700 -19.1100
9 C1a C 29.9600 -17.0100
10 N1a N 28.7700 -19.1100
BOND 10
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 2
8 7 9 1
9 7 10 1
10 6 8 1
|
|---|
